Therapeutic Asset Ratings

722 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fludarabine Severe Aplastic Anemia	Masonic Cancer Center, University of Minnesota	P2	BB (65)
Rapamycin Myelogenous Leukemia	Masonic Cancer Center, University of Minnesota	P2	BB (65)
TACROLIMUS Sickle Cell Disease	Masonic Cancer Center, University of Minnesota	P2	BB (65)
Busulphan Osteopetrosis	Masonic Cancer Center, University of Minnesota	P2/3	BB (65)
Fludarabine AML, Adult	Masonic Cancer Center, University of Minnesota	P3	BB (64)
PREDNISONE TABLETS Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (64)
Rapamycin Recurrent Chronic Lymphocytic Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (64)
TACROLIMUS Acute Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (64)
Anti-Thymoglobulin, Rabbit Lymphoma, Non-Hodgkin	Masonic Cancer Center, University of Minnesota	P2	BB (64)
MERCAPTOPURINE ANHYDROUS Burkitt's Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (64)
Rapamycin Burkitt Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (64)
TACROLIMUS Refractory Anemia	Masonic Cancer Center, University of Minnesota	P2	BB (64)
FILGRASTIM Minimal Residual Disease	Masonic Cancer Center, University of Minnesota	P2/3	BB (64)
Monomethyl Fumarate Acute Leukemia	Masonic Cancer Center, University of Minnesota	P3	B (63)
Allopurinol Chronic Myeloproliferative Disorders	Masonic Cancer Center, University of Minnesota	P2	B (63)
Anti-Thymoglobulin, Rabbit Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (63)
Cyclophosphamide Severe Aplastic Anemia	Masonic Cancer Center, University of Minnesota	P2	B (63)
Evomela Juvenile Myelomonocytic Leukemia (JMML)	Masonic Cancer Center, University of Minnesota	P2	B (63)
Evomela Recurrent Adult Lymphoblastic Lymphoma	Masonic Cancer Center, University of Minnesota	P2	B (63)
Fludarabine Hemoglobinopathies	Masonic Cancer Center, University of Minnesota	P2	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Hematopoietic and Lymphoid Cell Neoplasm	Masonic Cancer Center, University of Minnesota	P2	B (63)
Allopurinol Acute Lymphocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Allopurinol Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Cyclophosphamide Myelodysplastic Syndrome With Excess Blasts-1	Masonic Cancer Center, University of Minnesota	P2	B (62)
FILGRASTIM Severe Aplastic Anemia	Masonic Cancer Center, University of Minnesota	P2	B (62)

Showing 51 to 75 of 722 assets

PreviousPage 3 of 29Next